Log on / register
Feedback | Support | My details
Impact of invasive fungal infection on outcomes of severe sepsis: a multicenter matched cohort study in critically ill surgical patients.
Xie GH, Fang XM, Fang Q, Wu XM, Jin YH, Wang JL, Guo QL, Gu MN, Xu QP, Wang DX, Yao SL, Yuan SY, Du ZH, Sun YB, Wang HH, Wu SJ, Cheng BL
Crit Care 2008, 12:R5
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.

Commentary   
Empiric anti-Candida therapy for patients with sepsis in the ICU: how little is too little?
Golan Y
Critical Care 2009, 13:180 (21 August 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]
2.


Research    
Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation
Zilberberg MD, Kothari S, Shorr AF
Critical Care 2009, 13:R94 (19 June 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
3.


Letter    
Discriminating invasive fungal infection from colonization
Blot S, Vandewoude K, Vogelaers D
Critical Care 2008, 12:412 (3 April 2008)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]

You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.